FACTORES ASOCIADOS A LA ADHERENCIA AL TRATAMIENTO DE MALARIA EN PIURA Y TUMBES-PERÚ

REFERENCIAS

1. Newton P, White N. Malaria: new developments in treatment and prevention. Ann Rev Med 1999; 50: 179-83.

2. Aramburú J, Ramal C, Witzig R. Malaria reemergence in the peruvian amazon region. Emerg infect Dis 1999; 5 (2): 209-15.

3. Ministerio de Salud. Estudio de cohorte del tratamiento de malaria. Programa Nacional de Control de Malaria y Otras Enfermedades Metaxénicas. Lima: MINSA; 1999.

4. Gomes M, Wayling S, Pang L. Interventions to improve the use of antimalarials in south-east Asia: an overview. Bull World Health Organ 1998; 76 (Suppl 1): 9-19.

5. Shwe T, Lwin M, Aung S. Influence of blister packaging on the efficacy of artesunate + mefloquine over artesunate alone in community based treatment of non severe falciparurn malaria in Myanmar. Bull World Health Organ 1998; 76 (Suppl 1): 35-41.

6. Qingjun L, Jihui D, Laiyi T, Xiangjun Z, Jun L, Hay A, et al. The effect of drug packaging on patients' compliance with treatment for Plasmodium vivax malaria in China. Bull World Health Organ 1998; 76 (Suppl 1): 21-7.

7. Fungladda W, Honrado ER, Thimasarn K, Kitayaporn D, Karbwang J, Kamolratanakul P, et al. Compliance with artesunate and quinine + tetracycline treatment for uncomplicated talciparum malaria in Thailand. Bull World Health Organ 1998; 76 (Suppl 1): 59-66.

8. Atlas-ti. Versión 4.1. Scientific Software Development. Berlin; 1997.

9. Denis MB. Improving compliance with quinine + tetracycline for treatment of malaria: Evaluation of health education interventions in Cambodian Villages. Bull World Health Organ 1998; 76(Suppl 1): 59-66.

10. Liefooghe R, Suetens C, Meulemans H, Moron ME, Muynck A. A randomised trial of the impact of counselling on treatment adherence of tuberculosis patients in Sialkot, Pakistan. Int J Tuberc Lung Dis 1999; 3(12): 1073-80.

11. Morgan L. A decade review: methods to improve adherence to the treatment regimen among hemodialysis patients. Nephrol Nurs J 2000; 27(3): 299-304.

12. Chang AB, Shannon C, O'Neil MC, Tremann AM. Asthma management in indigenous children of a remote community using an indigenous health model. J Paediatr Child Health 2000; 36(3): 249-51.

13. Mc Pherson-Baker S, Malow RM, Penedo F, Klimas NG. Enhancing adherence to combination antiretroviral therapy in non-adherent HIV positive men. AIDS Care 2000; 12(4): 399-404.

14. Yépez M, Zambrano D, Carrasco F, Yépez R. Factores asociados con el cumplimiento del tratamiento antipalúdico en pacientes ecuatorianos. Rev Cuban Med Trop 2000; 52(2): 81-9.

15. Simpson SH, Farris KB, Johnson JA, Tsuyukil FIT Using focus groups to identify barriers to drug use in patients with congestive heart failure. Pharmacotherapy 2000; 20(7): 823-9.

16. Hofner R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999; 47(6): 555-67.

17. Ministerio de Salud. Vivir la tuberculosis. Estudio socioantropológico de la tuberculosis en dos zonas de alto riesgo de Lima: San Cosme y El Agustino. Lima: MINSA; 2000.

18. Johansson E, Long NH, Diwon VIK, Winfuist A. Attitudes to compliance with tuberculosis among women an men in Vietnam. Int J Tuberc Lung Dis 1999; 3(10): 862-8.

19. Alvarez-Gordillo GC, Alvarez-Gordillo JE, E Jiménez JE, Halperin-Frisch D. Perceptions and practices related with tuberculosis and treatment compliance in Chiapas, México. Salud Pública Méx. 2000; 42(6): 520-8.

20. Liefooghe R, Muynck AD. The dynamics of tuberculosis treatment adherence. J Pak Med Assoc 2001; 51(l): 3-9.

21. Kroeger A, Mancheno M, Ruiz W, Estrella E. Malaria y leishmaniasis cutánea en el Ecuador. Centro Latinoamericano del Instituto de Higiene Tropical y Salud Pública, Universidad de Heidelberg. Heidelberg; 1993.

22. Polo Friz H, Dain A. Treatment with tuberculostatic drugs: compliance at a general hospital. Rev Fac Cienc Med Univ Nac C6rdoba 1997; 55(1-2): 21-5.

23. Gao Y, Nau DP, Rosenhluth SA, Scoff V, Woodward C. The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care 2000; 12(4): 387-98.

24. Wilairatana P, Krudsood S, Chokejindachal W, Bussaratid V, Silachamroon U, Viriyavejakul P, et al. A clinical trial of combination of artesunate and mefloquine in the treatment of acute uncomplicated falciparum malaria: a short and practical regimen. Southeast Asian J Trop Med Public Health 1998; 29(4):696-701.

25. Ko Ko H. The study of the efficacy and safety of oral dihydroartenisinin tablet (cotecxin) on uncomplicated Plasmodium falciparum malaria patients. In: The Myanmer Medical Association Speciality Conference. Mandalay; 1995.

26. Liam CK, Lim KH, Tang BG. Attitudes and knowledge of newly diagnosed tuberculosis patients regarding the disease, and factors affecting treatment compliance. Int J Tuberc Lung Dis 1999; 3(4): 300-9.

27. Petersen E, Ronne T, Roon A, Bygberj 1, Larsen SO. Reported side effects to chloroquine, chloroquine plus proguanil, and mefloquine as chernoprophylaxis against malaria in Danish travelers. J Travel Med 2000; 7(2): 79?84.

28. Chattergee S. Compliance of malaria chemoprophylaxis among travelers to India. J Travel Med 1999; 6(1): 7-11.

29. Abraham C, Clift S, Grabowski P. Cognitive predictors of adherence to malaria prophylaxis regimens on return from a malarious region: a prospective study. Soc Sci Med 1999; 48(11):1641-54.

30. Martínez E, Solera J, Serna E, Cuenca D, Castillejos ML, Espinoza A, Saez L Compliance, tolerance and effectiveness of a short chernoprophylaxis regimen for the treatment of tuberculosis. Med Clin (Barc) 1998; 111 (11): 401-4.

31. Nuwaha F. High compliance in an ambulatory tuberculosis treatment programe in a rural community of Uganda. Int J Tuberc Lung Dis 1999; 3(1): 79-81.

32. Jasmer RM, Snyder DC, Daley CL. Twelve months of isoniazid compared with four months of isoniazid and rifampin for persons with radiographic evidence of previous tuberculosis: an outcome and cost-effectiveness analysis. Am J Respir Crit Care Med 2000; 162(5): 1648-52.

33. Roberts KJ, Mann T Barriers to antiretroviral medication adherence in HIV-infected women. AIDS Care 2000; 12(4):377-86.

34. Scott RA, Chatoo SD, Sander JW. The treatment of epilepsy in the developing countries: where do we go from here?. Bull World Health Organ 2001; 79(4): 344-51.

35. Mong O, Liu X, Shi J. Comparing the service and quality of private and public clinics in rural China. Health Policy Plan 2000; 15(4): 349-56.

36. Kaneko A, Taleo G, Kalkoa M, Yamar S, Kobayakowa T, Bjorkman A. Malaria erradication on islands. Lancet 2000; 356(9241): 1560-4.

37. Isema MD. Management of multidrug-resistant tuberculosis. Chemotheraphy 1999; 45(Suppl 2): 3-11.

38. Ministerio de Salud. Estudio de los condicionantes de la morbimortalidad por malaria grave producida por el Plasmodium falciparum. Lima: MINSA; 2001.

39. Desvarleuro M, Hyppolite PR, Pape JW. A novel approach to directly observed therapy for tuberculosis in an HIV-endemic area. Am J Public Health 2001; 91(l): 138-41.

40. Balasubramanian VN, Oommen K, Samuel R. DOT or not? Direct observation of ant?tuberculosis treatment and patent outcomes, Kerala state, India. Int J Tuberc Lung Dis 2000; 4(5): 400-13.

41. Al-Hajjaj MS, Al-Khatim IM. High rate of non-compliance with antituberculosis treatment despite a retrieval system: a call for implementation of directly observed therapy in Saudi Arabia. Int J Tuberc Lung Dis 2000; 4(4): 345-9.

42. Corvick J, Thompson S, Edlin BR, Watlers BK Incentives and accesibility: a pilot study to promote adherence to TB prophylaxis in a high-risk community. J Urban Health 1999; 76(4): 461-7.

43. Akkslip S, Rasmithat S, Sawert H. Direct observation of tuberculosis treatment by supervised family members in Yasothorn Province, Thailand. Int J Tuberc Lung Dis 1999; 3(12): 1061-5.

44. Davidson BL. A controlled comparison of directly observed therapy vs. self-administered therapy for active tuberculosis in the urban United States. Chest 1998; 114(5): 1239-43.

45. Pineda Y, Palma H. Capacitación de promotores de salud para la formación grupal de mujeres en áreas rurales para trabajar en presencia de ETS-VIH/SIDA. En: CongresoCentroamericano de Enfermedades de Transmisión Sexual. Lima; 1997.

46. Cook SV, Fujwara PJ, Friedan TR. Rates and risk factors for discontinuation of rifampicin. Int J Tuberc Lung Dis 2000; 4(2): 118-22.

47. Galván F, Santiuste C. Factors related with compliance with tuberculosis chemoprophylaxis. Med Clin (Barc) 1998; 111(17): 655-7.

48. Heal G, Elwood RK. Fitzgerald JM. Acceptance and safety of directly observed versus self-administered isoniazid preventive therapy in aboriginal people in British Columbia. Int J Tuberc Lung Dis 1998; 2(12): 979-83.

49. Minodier P, Lanza?Sillol F, Unal D. Imported pediatric malaria in Marseille. Arch Pediatr 1999; 6(9): 935-43.

50. Ishikawa N. Tuberculosis among inmigrants in Japan-epidemiological, clinical and sociological features, and the future of control. Kekkaku 1995; 70(12): 691-703.

51. King K, Dorner Rl. Are health undertakings effective in follow-up of migrants for tuberculosis? Med J Aust 1995; 163(8): 407-11.

52. Comolet TM, Rakotornalala R, Rajaonarioa H. Factors determining compliance with tuberculosis treatment in an urban environment, Tamatave, Madagascar. Int J Tuberc Lung Dis 1998; 2(11): 891?7.

53. Vaahtera M, Kulmala T, Maleta K, Culliman T, Salim ML, Ashorn R Chilhood inmunization in rural Malawi: time of administration and predictors of non-compliance. Ann Trop Paediatr 2000; 20(4): 305-12.

54. Wright MT. The old problem of adherence: research on treatment adherence and its relevance for HIV/AIDS. AIDS Care 2000; 12(6): 703-10.

55. Dinh Long L, Thi Yen P, Van Nhu T, Nguyen L. Use and quality ed antimalarial drugs in the private sector in Vietnam. Bull World Health Organ 1998; 76(Suppl 1): 51-8.


Regresar al Artículo

Volumenes anteriores

Listado por Títulos